Blau Farmacêutica

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Did Larsen & Toubro really win Rs 55,000Cr order? Official TenneT filing points to a different figure

A smart-glasses engineering workspace reflects Magic Leap’s 269 planned job cuts as the augmented reality pioneer exits first-party devices and pivots towards supplying waveguides and optical technology for artificial intelligence glasses. Representative image.

Magic Leap layoffs rise to 269 as augmented reality pioneer abandons first-party devices

Representative image showing large-scale iron ore mining operations, reflecting investor focus on Rio Tinto plc’s capital intensity, iron ore margins, and balance-sheet pressures following its 2025 results and share price decline.

Fortescue (ASX: FMG) shares fall as $525m Iron Bridge impairment overshadows record shipments

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

How Brazilian drugmaker Blau Farmacêutica quietly built a pembrolizumab biosimilar that could challenge Big Pharma

Blau Farmacêutica completes Brazil’s first full pembrolizumab biosimilar. Find out how this could reshape global immunotherapy access and biosimilar strategy.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
Zynga
Zynext Ventures USA LLC

January 24, 2026